![Claudia Ordonez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Claudia Ordonez
Keine laufenden Positionen mehr
Karriereverlauf von Claudia Ordonez
Ehemalige bekannte Positionen von Claudia Ordonez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KEROS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 | 30.07.2021 |
AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.11.2018 | 01.09.2019 |
Flatley Discovery Lab LLC
![]() Flatley Discovery Lab LLC Miscellaneous Commercial ServicesCommercial Services Flatley Discovery Lab LLC performs medical research activities. The non-profit company is based in Charlestown, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2015 | 01.10.2018 |
BIOGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2012 | 01.10.2015 |
VERTEX PHARMACEUTICALS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2006 | 01.06.2012 |
Ausbildung von Claudia Ordonez
University of Maryland | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
KEROS THERAPEUTICS, INC. | Health Technology |
BIOGEN INC. | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
Private Unternehmen | 2 |
---|---|
Akcea Therapeutics, Inc.
![]() Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Flatley Discovery Lab LLC
![]() Flatley Discovery Lab LLC Miscellaneous Commercial ServicesCommercial Services Flatley Discovery Lab LLC performs medical research activities. The non-profit company is based in Charlestown, MA. | Commercial Services |
- Börse
- Insiders
- Claudia Ordonez
- Erfahrung